GB201615050D0 - Microparticles - Google Patents

Microparticles

Info

Publication number
GB201615050D0
GB201615050D0 GBGB1615050.0A GB201615050A GB201615050D0 GB 201615050 D0 GB201615050 D0 GB 201615050D0 GB 201615050 A GB201615050 A GB 201615050A GB 201615050 D0 GB201615050 D0 GB 201615050D0
Authority
GB
United Kingdom
Prior art keywords
microparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1615050.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spheritech Ltd
Original Assignee
Spheritech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spheritech Ltd filed Critical Spheritech Ltd
Priority to GBGB1615050.0A priority Critical patent/GB201615050D0/en
Publication of GB201615050D0 publication Critical patent/GB201615050D0/en
Priority to US16/330,184 priority patent/US10471130B2/en
Priority to EP17768043.6A priority patent/EP3506887A1/en
Priority to PCT/EP2017/072270 priority patent/WO2018042059A1/en
Priority to GB1714257.1A priority patent/GB2558976B/en
Priority to JP2019533688A priority patent/JP7123935B2/ja
Priority to ZA2019/02128A priority patent/ZA201902128B/en
Priority to US16/590,854 priority patent/US11273207B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1615050.0A 2016-09-05 2016-09-05 Microparticles Ceased GB201615050D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1615050.0A GB201615050D0 (en) 2016-09-05 2016-09-05 Microparticles
US16/330,184 US10471130B2 (en) 2016-09-05 2017-09-05 Microparticles
EP17768043.6A EP3506887A1 (en) 2016-09-05 2017-09-05 Microparticles
PCT/EP2017/072270 WO2018042059A1 (en) 2016-09-05 2017-09-05 Microparticles
GB1714257.1A GB2558976B (en) 2016-09-05 2017-09-05 Microparticles
JP2019533688A JP7123935B2 (ja) 2016-09-05 2017-09-05 微粒子
ZA2019/02128A ZA201902128B (en) 2016-09-05 2019-04-04 Microparticles
US16/590,854 US11273207B2 (en) 2016-09-05 2019-10-02 Microparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1615050.0A GB201615050D0 (en) 2016-09-05 2016-09-05 Microparticles

Publications (1)

Publication Number Publication Date
GB201615050D0 true GB201615050D0 (en) 2016-10-19

Family

ID=57140038

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1615050.0A Ceased GB201615050D0 (en) 2016-09-05 2016-09-05 Microparticles
GB1714257.1A Active GB2558976B (en) 2016-09-05 2017-09-05 Microparticles

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1714257.1A Active GB2558976B (en) 2016-09-05 2017-09-05 Microparticles

Country Status (6)

Country Link
US (2) US10471130B2 (enExample)
EP (1) EP3506887A1 (enExample)
JP (1) JP7123935B2 (enExample)
GB (2) GB201615050D0 (enExample)
WO (1) WO2018042059A1 (enExample)
ZA (1) ZA201902128B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119500071A (zh) * 2024-11-25 2025-02-25 广东龙康方承医疗器械有限公司 毒素吸附蛋白复合物、毒素去除方法及其制成的毒素吸附器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689418B1 (fr) 1992-04-03 1994-07-01 Centre Nat Rech Scient Procede de preparation de micro-capsules ou de liposomes de tailles controlees par application d'un cisaillement constant sur une phase lamellaire.
DE102006016307B4 (de) 2006-04-06 2011-07-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 80686 Thermisch stabile Matrixmikropartikel und Mikrokapseln für die Kunststoffadditivierung und Verfahren zu ihrer Herstellung und ihre Verwendung
JP4918880B2 (ja) 2007-05-23 2012-04-18 日産化学工業株式会社 ジルコニアゾルの製造方法
PL2014280T3 (pl) 2007-07-13 2015-04-30 Cc Ery Gmbh Mikrocząsteczki, substytut krwi i sposób ich formowania
US8729108B2 (en) 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
US20150119427A1 (en) 2008-06-17 2015-04-30 Epikinetics Pharma, LLC Waterborne topical compositions for the delivery of azelaic acid for treatment of skin conditions such as acne vulgaris, rosacea, seborrheic dermatitis
JP5233482B2 (ja) 2008-07-31 2013-07-10 東レ株式会社 共重合ポリアミド、それよりなる微粒子および炭素繊維強化複合材料
GB201106742D0 (en) * 2011-04-20 2011-06-01 Spheritech Ltd Cross-linked poly-e-lysine
EP2991627B1 (en) 2013-05-03 2018-09-05 Washington University Blood substitute composition and method of use
GB201503566D0 (en) 2015-03-03 2015-04-15 Spheritech Ltd Microparticles

Also Published As

Publication number Publication date
GB201714257D0 (en) 2017-10-18
US11273207B2 (en) 2022-03-15
US20200038490A1 (en) 2020-02-06
US20190201497A1 (en) 2019-07-04
ZA201902128B (en) 2021-01-27
GB2558976A (en) 2018-07-25
JP7123935B2 (ja) 2022-08-23
WO2018042059A1 (en) 2018-03-08
GB2558976B (en) 2021-10-20
EP3506887A1 (en) 2019-07-10
US10471130B2 (en) 2019-11-12
JP2019526640A (ja) 2019-09-19

Similar Documents

Publication Publication Date Title
DK3512547T3 (en) Anti-pd-1-antistoffer
DK3504696T3 (en) Optisk kommunikativt batteristyringssystem
DK3482386T3 (en) Patientsimulator
AU201616677S (en) Cylindres
ZA201706362B (en) Microparticles
DK3438253T3 (en) Phytasemutant
DK3468998T3 (en) Anti-tnfrsf25-antistoffer
DK3270751T3 (en) Foodprocessor
AU201710564S (en) Bookrack
GB201609940D0 (en) Microparticles
DK3440392T3 (en) Styreapparat
PL3469691T3 (pl) Konfiguracja szyku halbacha
ZA201902128B (en) Microparticles
DK3430092T3 (en) Coatingsystem
AU201713059S (en) SUNSHADE - square
IL252855A0 (en) Polymer microparticles
AU5499P (en) T15-1218 Bituminaria bituminosa
AU201713060S (en) SUNSHADE - triangle
GB201621467D0 (en) Modified bulgeomers
HK1224980B (en) Microparticles
AU2016376V (en) NinbellaPurple Alyogyne huegelii
AU2016362V (en) JCU9 Desmanthus pernambucanus
AU2016360V (en) JCU7 Desmanthus leptophyllus
AU2016359V (en) JCU6 Desmanthus bicornutus
AU2016361V (en) JCU8 Desmanthus virgatus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)